ciprofloxacin has been researched along with pefloxacin in 233 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 92 (39.48) | 18.7374 |
| 1990's | 89 (38.20) | 18.2507 |
| 2000's | 33 (14.16) | 29.6817 |
| 2010's | 15 (6.44) | 24.3611 |
| 2020's | 4 (1.72) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, P; Cisek, EP; Cornell, CP; Elliott, NC; Gootz, TD; Haskell, SL; Hindahl, MS; Jefson, MR; Mann, DD; McGuirk, PR | 1 |
| Cohen, MA; Domagala, JM; Mailloux, GB; Roland, GE; Suto, MJ | 1 |
| Bridges, AJ; Bucsh, R; Domagala, JM; Gogliotti, RD; Hagen, SE; Heifetz, CL; Joannides, ET; Sanchez, JP; Sesnie, JC; Shapiro, MA | 1 |
| Dunne, TS; Kuck, NA; Lin, YI; Moran, DB; Ziegler, CB | 1 |
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Baroni, M; Cecchetti, V; Cianchetta, G; Cruciani, G; Mannhold, R | 1 |
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
| Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Bremont, S; Charavay, F; Courvalin, P; Goarant, C; Le Hello, S; O'Connor, O; Page, S; Vernel-Pauillac, F | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chhasatia, MR; Gandhi, DS; Patel, MN | 1 |
| Brillault, J; Couet, W; De Castro, WV | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cheng, XW; Fan, YL; Feng, LS; Wu, JB; Zhang, FZ | 1 |
| Gao, F; Wang, T; Xiao, J; Zhang, X | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Denis, JP; Gouin, F; Martin, C | 1 |
| Bergogne-Bérézin, E; Joly-Guillou, ML | 2 |
| Jabarit-Aldighieri, N; Raoult, D; Torres, H | 1 |
| Chidiac, C; Mouton, Y; Senneville, E | 1 |
| Breimer, DD; de Boer, AG; Jaehde, U; Langemeijer, MW | 1 |
| Lang, R; Rubinstein, E; Shasha, B | 1 |
| Bush, V; Korshunov, VM; Romanchuk, LA | 1 |
| Aubert, G; Dorche, G; Pozzetto, B | 1 |
| Amyes, SG; Lewin, CS | 1 |
| Deloron, P; Gaudin, C; Lebras, J; Malhotra, K; Pocidalo, JJ; Salmon, D | 1 |
| Räisäinen, S; Schildt, R; Syrjälä, H | 1 |
| Byl, B; Jacobs, F; Thys, JP | 1 |
| Busch, W; Dugasheva, LG; Gorodinskaia, VS; Il'chenko, AA; Korshunov, VM; Radakova, ED; Romanchuk, LA; Zhukhovitskiĭ, VG | 1 |
| Brook, I; Elliott, TB | 1 |
| Davidson, RJ; Hoban, DJ; Phillips, R; Zhanel, GG | 1 |
| Mnatsakanian, VE; Padeĭskaia, EN | 1 |
| McQueen, CA; Queener, SM; Schlüter, G; Way, BM; Williams, GM | 1 |
| Janknegt, R | 1 |
| al-Shammary, FJ; Bishop, SJ; Shibl, AM; Shoeb, HA; Tawfik, AF | 1 |
| Anderson, R; Joone, G; van Rensburg, CE | 1 |
| Christ, W | 1 |
| Boeckk, M; Borner, K; Deppermann, N; Höffken, G; Koeppe, P; Lode, H | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Padeĭskaia, EN; Shipilova, LD; Stebaeva, LF | 1 |
| Bailly, S; Fay, M; Gougerot-Pocidalo, MA | 1 |
| Brook, I; Elliott, TB; Ledney, GD | 1 |
| Guenounou, M; Miguères, ML; Ronco, E | 1 |
| Midtvedt, T | 1 |
| Gaillot, J; Montay, G | 1 |
| Biron, F; Boibieux, A; Peyramond, D; Tigaud, S | 1 |
| Dameron, G; Dournon, E; Pocidalo, JJ; Rajagopalan-Levasseur, P; Vilde, JL | 1 |
| Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O | 1 |
| Campos, LC; dos Reis, EM; Ribeiro Dias, JC | 1 |
| Jones, RN | 1 |
| Deforges, L; Duval, J; Leclercq, R; Soussy, CJ | 1 |
| Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M | 1 |
| Aubert, G; Denis, M; Dorche, G; Loboguerrero, M; Lucht, F; Puech, C | 1 |
| Bernard, E; Dellamonica, P; Drugeon, HB; Etesse, H; Garraffo, R | 1 |
| Akalin, HE; Akyön, Y; Diker, S; Gür, D; Hasçelik, G | 1 |
| Allen, W; Gorzynski, EA; Gutman, SI | 1 |
| Bricaire, F; Godeau, B; Karam, D; Leport, C; Salmon, D; Vildé, JL | 1 |
| Aravantinos, D; Gazis, J; Giamarellou, H; Kolokythas, E; Petrikkos, G; Sfikakis, P | 1 |
| Fong, IW | 1 |
| Barzilai, A; Lev, B; Rubinstein, E; Schwartz, E; Somekh, E | 1 |
| Dailloux, M; Henry, C; Petitpain, N; Weber, M | 1 |
| Dewachter, P; Dopff, C; Dureux, JB; Phelisse, F; Tronel, H; Voiriot, P; Weber, M | 1 |
| Kazmierczak, A; Nordmann, P; Pechinot, A | 1 |
| Shah, PM | 2 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Neu, HC | 1 |
| Douer, D; Rubinstein, E; Shaked, N; Somekh, E | 1 |
| Hooper, DC; Wolfson, JS | 1 |
| Boerema, JB; von Summeren, TR; Willems, FT | 1 |
| Baur, C; Davies, BI; Maesen, FP; Teengs, JP | 2 |
| Boerema, JB | 1 |
| Geitz, JN; Lerk, CF; Tarko-Smit, NJ; Van Saene, HK; Van Saene, JJ | 1 |
| Brouwers, JR; Groeneveld, AJ | 1 |
| Edlund, C; Nord, CE | 2 |
| King, A; Phillips, I | 2 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Bouanchaud, DH; Huet, Y; Rolin, O | 1 |
| Avesani, V; Delmee, M | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Borner, K; Lode, H | 1 |
| Høiby, N | 1 |
| Cellini, L; Oliva, B; Renzini, G; Scazzocchio, F; Schippa, S; Selan, L | 1 |
| Fass, RJ; Helsel, VL | 1 |
| Clarke, AM; Zemcov, SJ | 1 |
| Davies, S; Sparham, PD; Spencer, RC | 1 |
| Habiyaremye, I; Vandepitte, J; Verbist, L | 1 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC; Regamey, P | 1 |
| Pattyn, SR; Van Caekenberghe, DL; Verhoeven, JR | 1 |
| Bébéar, C; Fourche, J; Mormède, M; Texier-Maugein, J | 1 |
| Fay, M; Gougerot-Pocidalo, MA; Roche, Y | 2 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| Duval, J; Leclercq, R; Soussy, CJ | 1 |
| Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Bebear, C; de Barbeyrac, B; Quentin, C; Renaudin, H | 1 |
| De Lepeleire, I; De Schepper, PJ; Tjandra-Maga, TB; Van Hecken, A; Verbesselt, R | 1 |
| Denamur, E; Laurans, G; Orfila, J; Suermondt, G | 1 |
| Bremner, DA; Dickie, AS; Singh, KP | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Gordin, FM; Hackbarth, CJ; Sande, MA; Scott, KG | 1 |
| Dabernat, H; Delmas, C; Lareng, MB | 1 |
| Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L | 1 |
| Tunçkanat, F; Yuluğ, N | 1 |
| Cattier, B; Gavignet, M; Goudeau, A; Koubaa, N; Quentin, R | 1 |
| Kawakami, K; Kondo, H; Sakamoto, F; Tsukamoto, G | 1 |
| Deforges, L; Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F | 1 |
| Bersani, C; Bertoletti, R; Fietta, A; Gialdroni Grassi, G; Santagada, T | 1 |
| Rietbrock, N; Staib, AH | 1 |
| Andrews, JM; Griggs, D; Lister, D; McNulty, CA; Wise, R | 1 |
| Boogaerts, MA; Malbrain, S; Scheers, W; Verwilghen, RL | 1 |
| Appelbaum, PC; Sollenberger, L; Spangler, SK | 1 |
| Dabbs, DJ; Limb, DI; Spencer, RC | 1 |
| Arpi, M; Bentzon, MW; Gahrn-Hansen, B; Søgaard, P | 1 |
| Mazzei, T; Nicoletti, P; Periti, P | 1 |
| Barry, AL; Jones, RN | 1 |
| Wolff, M | 1 |
| Smith, CR | 1 |
| Kawane, H; Niki, Y; Soejima, R; Sumi, M; Umeki, S | 1 |
| Baars, AM; van Herwaarden, CL; Vree, TB; Wijnands, WJ | 2 |
| Akalin, E; Baykal, M | 1 |
| Etienne, D; Fay, M; Forest, N; Gougerot-Pocidalo, MA; Pocidalo, JJ; Roche, Y | 1 |
| Davies, BI; Maesen, FP | 1 |
| Giroir, AM; Grosset, JH; Guelpa-Lauras, CC; Perani, EG | 1 |
| Chu, DT; Claiborne, AK; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG; Pihuleac, E | 1 |
| Hoogkamp-Korstanje, JA | 2 |
| Meier-Ewert, H; Millott, G; Weil, G | 1 |
| Arcidiacono, MM; Cogo, R; Fraschini, F; Monzani, GP; Scaglione, F; Scamazzo, F | 1 |
| Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Jehl, F; Le Conte, P; Potel, G; Stephant, G; Xiong, YQ | 1 |
| Baron, D; Bugnon, D; Caillon, J; Conte, PL; Drugeon, HB; Potel, G; Xiong, YQ | 1 |
| Beaucaire, G; Chidiac, C; Guery, B; Roussel-Delvallez, M | 1 |
| Dellamonica, P; Fabre, R; Meyran, M; Moreau, N; Thabaut, A | 1 |
| Kasatkina, IV; Lozovoĭ, NV; Pasiukov, VV; Shcherbaniuk, AI | 1 |
| D'iakov, SI; Katsalukha, VV; Lebedeva, IK; Lukashina, AV; Raĭskaia, VA | 1 |
| Kasatkina, IV; Ryzhko, IV; Shcherbaniuk, AI | 1 |
| Arman, D; Tural, D; Willke, A | 1 |
| Chauveaux, D; Le Huec, JC; Le Rebeller, A; Moinard, M; Rivel, J; Schaeverbeke, T | 1 |
| Guibert, J | 1 |
| Goldwasser, R; Keren, G; Keysary, A; Rubinstein, E | 1 |
| Domarle, O; Hayem, G; Pocidalo, JJ; Thuong-Guyot, M | 1 |
| Baron, DI; Bugnon, D; Caillon, J; Drugeon, HB; Juvin, ME; Le Conte, P; Potel, G; Xiong, YQ | 1 |
| Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM | 1 |
| Kasatkina, IV; Makarovskaia, LN; Padeĭskaia, EN; Sherbaniuk, AI | 1 |
| Iakovlev, VP | 1 |
| Griffiths, NM; Hirst, BH; Simmons, NL | 1 |
| Croizé, J; Le Noc, D; Le Noc, P | 1 |
| Auckenthaler, R; Peyret, M; Rohner, P | 1 |
| Gabriel, L; Giamarellou, H; Kanellas, D; Kavouklis, E; Petrikkos, G | 1 |
| Fekete, I; Kelentey, BA; Kelentey, BJ; Kozma, J | 1 |
| Kluytmans, JA; Stolz, E; van Rijsoort-Vos, JH; Verbrugh, HA | 1 |
| Ahmedy, A; Khardori, N; Toama, M; Yassien, M | 1 |
| Iakovlev, SV; Iakovlev, VP; Izotova, GN | 1 |
| Besednova, NN; Shubin, FN; Zaĭtseva, EA | 2 |
| Chan, RK; Cheong, LL; Goh, CL; Leow, YH; Nadarajah, M | 1 |
| Bergogne-Bérézin, E; Houot, S; Joly-Guillou, ML; Moreau, NJ | 1 |
| Anan'eva, LP; Belov, BS; Nasonova, VA; Shubin, SV; Soldatova, SI; Tarasova, GM; Urumova, MM; Ushakova, MA | 1 |
| Hybenová, D; Majtán, V | 1 |
| Ioannou, PC; Lianidou, ES; Veiopoulou, CJ | 1 |
| Hostacká, A; Majtán, V | 1 |
| Majtán, V; Majtánová, L | 2 |
| Goumas, PD; Moschovakis, ED; Naxakis, SS; Papavasiliou, DA; Skoutelis, A; Tsintsos, SJ | 1 |
| Prabhu, S; Rewari, S | 1 |
| Abo Rahmy, E | 1 |
| Baumann-Wilschke, I; Förster, C; Rücker, M; Shakibaei, M; Stahlmann, R; Vormann, J | 1 |
| Gikas, A; Kofterithis, D; Psaroulaki, A; Spyridaki, I; Tselentis, Y | 1 |
| Anastassiadis, A; Andreopoulos, A; Dounis, E; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Kolia, M; Korakis, T | 1 |
| Bosse, D; Kubin, R; Schacht, P | 1 |
| Mayer, I; Nagy, E | 2 |
| Acar, JF; Goldstein, FW; Kitzis, MD; Miegi, M | 1 |
| Antolic, G; Grabnar, I; Kozjek, F; Mrhar, A; Suturkova, LJ | 1 |
| Abd-Allah, AR; Abdel-Aziz, AA; Aly, HA; Hamada, FM; Moustafa, AM | 1 |
| Besednova, NN; Shubin, FN; Zaĭtseva, EF | 1 |
| Smirnova, LB; Sokolova, VI | 1 |
| Fernández, F; Martínez-Martínez, L; Perea, EJ | 1 |
| Bark, KM; Cho, YH; Heo, EP; Kim, TH; Sun, YW; Yoon, TJ | 1 |
| Khardori, N; Yassien, M | 1 |
| Postnikov, SS | 1 |
| Alla, EA; El-Sadek, M; Mostafa, S | 1 |
| Bébéar, C; Bébéar, CM; Charron, A; Gonzalez, P; Raherison, S; Renaudin, H | 1 |
| Cambourieu, C; Nourry, H; Pouzaud, F; Rat, P; Warnet, JM | 1 |
| Nazhimov, VP; Novichkova, GA; Postnikov, SS; Semykin, SIu | 1 |
| Khaliq, Y; Zhanel, GG | 1 |
| Coban, AY; Durupinar, B | 1 |
| Köşem, M; Ozbek, H; Tuncay, I; Unal, O | 1 |
| Mohan, J; Rao, GS; Sastry, KV; Singh, RV; Tyagi, JS | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Takač, MJ | 1 |
| Beytemur, O; Gulmez, T; Kaleagasioglu, F; Mutlu, Z; Olcay, E; Olgac, V | 1 |
| Betlejewska-Kielak, K; Biernacka, J; Grudzień, M; Kłosińska-Szmurło, E; Mazurek, AP; Pluciński, FA | 1 |
| Åhman, J; Kahlmeter, G; Matuschek, E; Petersen, A; Sjölund-Karlsson, M; Skov, R; Stegger, M; Torpdahl, M | 1 |
| Fang, FC | 1 |
| Laiq, S; Moin, S; Raheem, A; Zafar, A; Zeeshan, M | 1 |
| Gao, Y; Ji, Y; Lin, Y; Lin, Z; Lu, Y; Yang, Y; Zhang, L | 1 |
| Gui, D; Hua, P; Krebs, P; Wu, S; Ying, G; Zhang, J | 1 |
| Guo, L; Kuang, H; Lei, X; Liu, L; Xu, C; Xu, L | 1 |
| Chan, RK; Cheong, LL; Nadarajah, M | 1 |
| Arcidiacono, MM; Fraschini, F; Gattei, G; Mezzetti, M; Scaglione, F | 1 |
| Chauveaux, D; Dehais, J; Le Huec, JC; Le Rebeller, A; Rivel, J; Schaeverbeke, T | 1 |
| Gutmann, L; Janoir, C; Kitzis, MD; Moreau, NJ; Zeller, V | 2 |
| Bouquet, S; Couet, W; de Boer, AG; de Lange, EC; Delon, A; Marchand, S; van den Berg, D; van der Sandt, IC | 1 |
| Chaves, J; del Carmen Conejo, M; Hernández, G; Joyanes, P; Martínez-Martínez, L; Pascual A, A; Perea, EJ | 1 |
| Christmann, D; Daniel, JP; Moulin, B | 1 |
| Keam, SJ; Perry, CM | 1 |
| Iannetta, M; Mineo, E; Neri, MG; Pessina, A | 1 |
17 review(s) available for ciprofloxacin and pefloxacin
| Article | Year |
|---|---|
Fluoroquinolone derivatives and their anti-tubercular activities.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Quinolone hybrids and their anti-cancer activities: An overview.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Quinolones; Structure-Activity Relationship | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
[Value of quinolones in the treatment of lower respiratory tract infections caused by intracellular organisms, excluding mycobacteria].
Topics: Anti-Infective Agents; Chlamydia Infections; Ciprofloxacin; Enoxacin; Erythromycin; Humans; In Vitro Techniques; Legionnaires' Disease; Ofloxacin; Pefloxacin; Pneumonia, Mycoplasma | 1992 |
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
CAPD peritonitis and fluoroquinolones: a review.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
Pharmacokinetics of fluoroquinolones in hepatic failure.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Half-Life; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Ofloxacin; Pefloxacin | 1990 |
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
Topics: Anti-Bacterial Agents; Bacteria; Blood Proteins; Ciprofloxacin; Enoxacin; Fluorine; Humans; Kidney; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Protein Binding; Quinolines; Urinary Tract Infections | 1985 |
A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
Topics: Ciprofloxacin; Enoxacin; Humans; Intestines; Naphthyridines; Norfloxacin; Ofloxacin; Oropharynx; Oxazines; Pefloxacin; Quinolines | 1988 |
Quinolones.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Cocci; Hospital Units; In Vitro Techniques; Methicillin Resistance; Ofloxacin; Pefloxacin | 1994 |
[Pharmacokinetics of fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin | 1993 |
[Pharmacokinetics of fluoroquinolones in patients with renal insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Pefloxacin; Quinolones; Renal Insufficiency | 1995 |
Fluoroquinolone-associated tendinopathy: a critical review of the literature.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Middle Aged; Pefloxacin; Risk Factors; Tendinopathy; Tendon Injuries | 2003 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
[Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Kidney Failure, Chronic; Ofloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 2004 |
12 trial(s) available for ciprofloxacin and pefloxacin
| Article | Year |
|---|---|
Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Topics: Anti-Infective Agents; Bronchitis; Ciprofloxacin; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Pefloxacin; Pneumonia; Pneumonia, Pneumococcal | 1991 |
The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Dermatitis; Enoxacin; Gram-Negative Bacteria; Humans; Ofloxacin; Osteomyelitis; Pefloxacin | 1989 |
Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
Topics: Administration, Oral; Adult; Ciprofloxacin; Fleroxacin; Humans; Male; Pefloxacin; Random Allocation | 1988 |
Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
Topics: Adult; Bacterial Infections; Bronchi; Bronchoalveolar Lavage Fluid; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Pefloxacin; Respiratory Tract Infections; Staphylococcus aureus | 1995 |
[Efficacy of single dose of ciprofloxacin and pefloxacin in the treatment of female acute cystitis].
Topics: Acute Disease; Administration, Oral; Adult; Ciprofloxacin; Cystitis; Double-Blind Method; Female; Humans; Middle Aged; Pefloxacin; Prospective Studies; Tablets | 1995 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Feces; Female; Fever; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neutropenia; Ofloxacin; Pefloxacin | 1994 |
Comparing the efficacy of pefloxacin and ciprofloxacin in the treatment of acute uncomplicated gonococcal urethritis in males.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; beta-Lactam Resistance; Ciprofloxacin; Gonorrhea; Humans; Male; Middle Aged; Neisseria gonorrhoeae; Pefloxacin; Urethritis | 1995 |
Kinetics of 4-fluoroquinolones permeation into saliva.
Topics: Adult; Anti-Infective Agents; Biological Transport; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Monitoring; Humans; Male; Norfloxacin; Ofloxacin; Pefloxacin; Saliva | 1999 |
[On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
Topics: Adolescent; Age Factors; Anemia, Aplastic; Anti-Infective Agents; Body Height; Cartilage; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Infant; Joint Diseases; Knee Joint; Male; Ofloxacin; Pefloxacin; Prospective Studies; Treatment Outcome | 2002 |
Residues of fluoroquinolone drugs in the cloacal gland and other tissues of Japanese quail.
Topics: Animals; Anti-Infective Agents; Brain; Ciprofloxacin; Cloaca; Coturnix; Drug Residues; Fluoroquinolones; Kidney; Male; Muscle, Skeletal; Pefloxacin; Testis; Time Factors | 2006 |
Penetration of pefloxacin and ciprofloxacin into lung tissue.
Topics: 4-Quinolones; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Lung; Male; Middle Aged; Pefloxacin; Quinolones | 1995 |
Prulifloxacin.
Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Bronchitis, Chronic; Ciprofloxacin; Clavulanic Acid; Dioxolanes; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Humans; Italy; Molecular Structure; New Zealand; Pefloxacin; Piperazines; Prodrugs; Quinolones; Urinary Tract Infections | 2004 |
205 other study(ies) available for ciprofloxacin and pefloxacin
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Aerobiosis; Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Infections; Cattle; Cattle Diseases; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Molecular Structure; Pasteurella Infections; Quinolones; Structure-Activity Relationship; Swine; Swine Diseases | 1992 |
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
Topics: Animals; Anti-Infective Agents; Cricetinae; Cricetulus; Fluoroquinolones; Microbial Sensitivity Tests; Structure-Activity Relationship | 1992 |
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Bacterial Infections; Female; Injections, Subcutaneous; Mice; Microbial Sensitivity Tests; Photosensitivity Disorders; Structure-Activity Relationship | 1992 |
Synthesis of novel 5-fluoro analogues of norfloxacin and ciprofloxacin.
Topics: Animals; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Molecular Structure; Norfloxacin; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 1989 |
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Chemometric studies on the bactericidal activity of quinolones via an extended VolSurf approach.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Escherichia coli; Models, Molecular; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Quinolones; Staphylococcus aureus; Thermodynamics | 2004 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.
Topics: Amino Acid Substitution; Base Sequence; DNA Gyrase; DNA Mutational Analysis; DNA Primers; DNA Probes; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Nucleic Acid Denaturation; Point Mutation; Polymerase Chain Reaction; Streptococcus pneumoniae; Thermodynamics | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Interaction of drug based binuclear mixed-ligand complexes with DNA.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Ciprofloxacin; Cobalt; DNA, Bacterial; Ligands; Magnetic Resonance Spectroscopy; Magnetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Oxidation-Reduction; Spectrophotometry, Infrared; Structure-Activity Relationship; Temperature; Viscosity | 2009 |
Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model.
Topics: Absorption; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport, Active; Cell Line; Cell Membrane Permeability; Cyclosporins; Diffusion; Drug Interactions; Drug Resistance, Bacterial; Epithelial Cells; Fluoroquinolones; Kinetics; Lipids; Lung | 2010 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Absence of recurrence with ciprofloxacin therapy of thrombocytopenia induced by pefloxacin].
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Humans; Male; Pefloxacin; Thrombocytopenia | 1992 |
In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp.
Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Pefloxacin; Quinolones | 1992 |
Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Coxiella burnetii; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Rickettsia; Rickettsia rickettsii; Viral Plaque Assay | 1992 |
Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats.
Topics: Animals; Biological Transport; Ciprofloxacin; Injections, Intravenous; Injections, Intraventricular; Male; Pefloxacin; Rats; Rats, Wistar; Solubility | 1992 |
Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
Topics: Administration, Oral; Animals; Brucellosis; Ciprofloxacin; Doxycycline; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
[Selective decontamination of the intestine and total gnotobiologic isolation in treatment of mice with acute radiation sickness].
Topics: Acute Disease; Amikacin; Animals; Ciprofloxacin; Decontamination; Germ-Free Life; Intestines; Mice; Mice, Inbred CBA; Opportunistic Infections; Pefloxacin; Radiation Injuries, Experimental | 1992 |
[In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; In Vitro Techniques; Naphthyridines; Pefloxacin; Quinolones; Streptococcus; Streptococcus agalactiae; Streptococcus bovis; Streptococcus pneumoniae; Streptococcus pyogenes; Streptococcus sanguis | 1991 |
Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
Topics: Anti-Infective Agents; Bacterial Proteins; Chloramphenicol; Ciprofloxacin; Escherichia coli; Fleroxacin; Pefloxacin; Rifampin; RNA, Bacterial | 1990 |
Activities of pefloxacin and ciprofloxacin against experimental malaria in mice.
Topics: Animals; Ciprofloxacin; Female; Malaria; Mice; Pefloxacin; Plasmodium yoelii; Staining and Labeling | 1990 |
In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Francisella tularensis; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Tularemia | 1991 |
[The experimental and clinical effect of ciprofloxacin on the microflora of the gastrointestinal tract].
Topics: Adult; Amikacin; Animals; Cimetidine; Ciprofloxacin; Digestive System; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Female; Germ-Free Life; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mice; Mice, Inbred CBA; Middle Aged; Pefloxacin; Time Factors | 1991 |
Quinolone therapy in the prevention of mortality after irradiation.
Topics: Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Cobalt Radioisotopes; Female; Gamma Rays; Mice; Ofloxacin; Pefloxacin; Radiation Injuries, Experimental | 1991 |
Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Physiological Phenomena; Ciprofloxacin; Culture Media; Humans; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Staphylococcus aureus | 1991 |
[Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Enoxacin; Meningoencephalitis; Mice; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 1991 |
Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; DNA; DNA Repair; Liver; Norfloxacin; Ofloxacin; Pefloxacin; Phosphorus Radioisotopes; Rats | 1991 |
Influence of new quinolones on normal immune capabilities.
Topics: Animals; Anti-Infective Agents; Antibody Formation; Ciprofloxacin; Hypersensitivity, Delayed; Immunity, Cellular; Injections, Intramuscular; Male; Mice; Norfloxacin; Ofloxacin; Pefloxacin; Phagocytosis | 1990 |
Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus.
Topics: Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Granulomatous Disease, Chronic; Humans; Neutrophils; Pefloxacin; Phagocytosis; Staphylococcus aureus | 1990 |
Central nervous system toxicity of quinolones: human and animal findings.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System; Ciprofloxacin; Dogs; Drug Interactions; Fleroxacin; Fluoroquinolones; gamma-Aminobutyric Acid; Humans; Injections, Intraventricular; Narcotic Antagonists; Pefloxacin; Quinolizines; Seizures; Theophylline | 1990 |
Quinolone pharmacokinetics and metabolism.
Topics: Administration, Oral; Anti-Infective Agents; Biological Availability; Biotransformation; Ciprofloxacin; Enoxacin; Fleroxacin; Half-Life; Humans; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin | 1990 |
[Effects of quinolone carboxylic acid derivatives on the ultrastructure of gram-positive and gram-negative bacteria].
Topics: Ciprofloxacin; In Vitro Techniques; Microscopy, Electron; Oxolinic Acid; Pefloxacin; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1990 |
[Effect of quinolones on TNF-alpha production by human monocytes].
Topics: Ciprofloxacin; Cyclic AMP; Dose-Response Relationship, Drug; Endotoxins; Humans; Leukocytes, Mononuclear; Ofloxacin; Pefloxacin; Tumor Necrosis Factor-alpha | 1990 |
Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin.
Topics: Animals; Ciprofloxacin; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Ofloxacin; Pefloxacin; Radiation Injuries, Experimental | 1990 |
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; In Vitro Techniques; Klebsiella pneumoniae; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype | 1990 |
The influence of quinolones on the faecal flora.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Feces; Humans; Intestines; Norfloxacin; Ofloxacin; Pefloxacin | 1990 |
[Treatment of salmonellosis and shigellosis with the new quinolones].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciprofloxacin; Dysentery, Bacillary; Female; Humans; Male; Middle Aged; Ofloxacin; Pefloxacin; Salmonella; Salmonella Infections; Shigella | 1990 |
Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1.
Topics: Cell Division; Ciprofloxacin; Humans; Intracellular Fluid; Legionella; Macrophages; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Serotyping; Time Factors | 1990 |
[Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype; Staphylococcus aureus | 1990 |
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin; Osteomyelitis; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
In vitro susceptibility of Salmonella to ciprofloxacin and pefloxacin compared with three other antibiotics.
Topics: Ampicillin; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Pefloxacin; Salmonella; Salmonella typhimurium; Serotyping; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Antimicrobial activity and interaction of pefloxacin and its principal metabolites. Collaborative Antimicrobial Susceptibility Testing Group.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Staphylococcus; Streptococcus | 1989 |
[In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fleroxacin; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin | 1989 |
The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Enterobacteriaceae Infections; Female; Fleroxacin; Half-Life; Pefloxacin; Rats; Serratia marcescens | 1989 |
[Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Serratia marcescens | 1989 |
Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
Topics: Administration, Oral; Adult; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Escherichia coli; Female; Humans; Male; Ofloxacin; Osteomyelitis; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 1989 |
[In vitro susceptibility of Campylobacter jejuni and Campylobacter coli to quinolone antibiotics].
Topics: Anti-Infective Agents; Campylobacter; Campylobacter jejuni; Ciprofloxacin; Feces; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin | 1989 |
Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Enoxacin; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Pefloxacin; Quinolones | 1989 |
[Chronic bone infections after surgery. Treatment with the new quinolones].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone Diseases; Ciprofloxacin; Female; Humans; Male; Middle Aged; Orthopedics; Pefloxacin; Postoperative Complications; Prospective Studies | 1989 |
Pharmacokinetics of three newer quinolones in pregnant and lactating women.
Topics: Adult; Ciprofloxacin; Female; Humans; Lactation; Maternal-Fetal Exchange; Milk, Human; Ofloxacin; Pefloxacin; Pregnancy; Pregnancy Trimester, Third | 1989 |
The effect of ciprofloxacin and pefloxacin on bone marrow engraftment in the spleen of mice.
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Ciprofloxacin; Female; Graft Survival; Mice; Pefloxacin; Spleen | 1989 |
[In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mycobacterium; Norfloxacin; Ofloxacin; Pefloxacin | 1989 |
[In vivo bactericidal effect of ciprofloxacin, ofloxacin and pefloxacin against Staphylococcus aureus].
Topics: Animals; Ciprofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1989 |
Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes.
Topics: Alanine Transaminase; Animals; Anti-Infective Agents; Aspartate Aminotransferases; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Ciprofloxacin; L-Lactate Dehydrogenase; Liver; Male; Ofloxacin; Pefloxacin; Rats; Rats, Inbred Strains | 1989 |
The role of quinolones in staphylococcal infection.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin; Staphylococcal Infections | 1989 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Osteomyelitis; Oxazines; Pefloxacin; Quinolines; Respiratory Tract Infections; Sexually Transmitted Diseases; Surgical Wound Infection; Urinary Tract Infections | 1987 |
In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
Topics: Cell Division; Ciprofloxacin; Hematopoietic Stem Cells; Humans; Leukemia; Pefloxacin; Tumor Cells, Cultured | 1989 |
The in-vitro comparative activity of quinolones against bacteria from urinary tract infections in general practice.
Topics: Anti-Infective Agents, Urinary; Bacteria; Ciprofloxacin; Enterococcus faecalis; Escherichia coli; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Staphylococcus; Urinary Tract Infections | 1986 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Neisseria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pneumococcal Infections; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 1986 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxacin; Prostatitis; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1986 |
Quinolones and colonization resistance in human volunteers.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Digestive System; Feces; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines | 1986 |
Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Spectrophotometry, Ultraviolet | 1986 |
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Ciprofloxacin; Clostridium; Enoxacin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in-vitro activity of pefloxacin.
Topics: Acinetobacter; Aeromonas; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacteroides; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gardnerella vaginalis; Haemophilus influenzae; Lactams; Neisseria gonorrhoeae; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Quinolines; Streptococcus | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
[Biotransformation of selected gyrase inhibitors].
Topics: Anti-Infective Agents; Biotransformation; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; R Factors | 1988 |
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of the new 4-quinolone compound Ro 23-6240.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Naphthyridines; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1987 |
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections | 1987 |
In vitro activity of five new quinolones against cultivable mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Enhancement of interleukin 2 production by quinolone-treated human mononuclear leukocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; In Vitro Techniques; Interleukin-2; Kinetics; Leukocytes, Mononuclear; Lymphocyte Activation; Mitomycin; Mitomycins; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Receptors, Immunologic; Receptors, Interleukin-2 | 1988 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
[In vitro antibacterial activity of piperacillin/quinolone combinations].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Synergism; Escherichia coli; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens | 1988 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Mycoplasmataceae; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Quinolones; Ureaplasma | 1988 |
[In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Pefloxacin; Respiratory Tract Infections | 1988 |
In-vitro activity of fleroxacin compared with three other quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Ciprofloxacin; Guinea Pigs; Half-Life; Microbial Sensitivity Tests; Nalidixic Acid; Neutropenia; Pefloxacin; Pneumonia; Pseudomonas Infections; Quinolines; Time Factors | 1985 |
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria meningitidis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Streptococcus pneumoniae | 1985 |
[Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Topics: Acinetobacter; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1985 |
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections | 1988 |
[The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Ofloxacin; Pefloxacin; Pseudomonas; Urinary Tract Infections | 1988 |
In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Female; Genital Diseases, Female; Genital Diseases, Male; Haemophilus; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1988 |
Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Ciprofloxacin; Escherichia coli Infections; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pharmaceutical Preparations; Prodrugs; Structure-Activity Relationship | 1988 |
[In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen | 1987 |
Fluoroquinolone derivatives: effects on neutrophil functional tests.
Topics: Anti-Infective Agents; Candida albicans; Chemotaxis, Leukocyte; Ciprofloxacin; Humans; In Vitro Techniques; Neutrophils; Norfloxacin; Ofloxacin; Pefloxacin; Phagocytosis; Staphylococcus aureus | 1987 |
Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Ciprofloxacin; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
[Gyrase inhibitors: unwanted central nervous system effects].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Brain Chemistry; Brain Diseases; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Solubility | 1987 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
The comparative pharmacokinetics of five quinolones.
Topics: Administration, Oral; Adult; Ciprofloxacin; Enoxacin; Half-Life; Humans; Infusions, Intravenous; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
Effects of quinolones on granulocyte function in vitro.
Topics: Anti-Infective Agents; Cell Survival; Ciprofloxacin; Hexosephosphates; Humans; Neutrophils; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Phagocytosis | 1986 |
Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.
Topics: Anti-Infective Agents; Cefpirome; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolines | 1986 |
In-vitro selection of bacteria resistant to the 4-quinolone agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Staphylococcus; Streptococcus | 1987 |
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Therapeutic contribution of the new quinolones].
Topics: Anti-Infective Agents; Bacterial Infections; Biotransformation; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Therapy, Combination; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
The adverse effects of fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
New synthetic quinolone antibacterial agents and serum concentration of theophylline.
Topics: Adult; Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Theophylline | 1987 |
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middle Aged; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
[Fluoroquinolones].
Topics: Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
Effects of quinolones on interleukin 1 production in vitro by human monocytes.
Topics: Adult; Anti-Infective Agents; Cell Division; Ciprofloxacin; HLA-DR Antigens; Humans; In Vitro Techniques; Interleukin-1; Kinetics; Monocytes; Norfloxacin; Pefloxacin; Penicillins; Phytohemagglutinins | 1987 |
Comparative effects of quinolones on human mononuclear leucocyte functions.
Topics: Cell Survival; Ciprofloxacin; Humans; Indomethacin; Interleukin-1; Lymphocyte Activation; Lymphocytes; Mercaptoethanol; Monocytes; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Clinical efficacy of the new quinolones in lower respiratory infections.
Topics: Aged; Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pefloxacin; Respiratory Tract Infections; Sputum | 1987 |
Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
Topics: Animals; Ciprofloxacin; Dapsone; Female; Half-Life; Kinetics; Leprosy; Mice; Mycobacterium leprae; Norfloxacin; Pefloxacin; Time Factors | 1987 |
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
Topics: Acinetobacter; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli; Female; Fluorine; Fluoroquinolones; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus; Streptococcus; Structure-Activity Relationship | 1985 |
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Respiratory Tract Infections; Trimethoprim; Urinary Tract Infections | 1984 |
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1984 |
Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.
Topics: Animals; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Fosfomycin; Pefloxacin; Pseudomonas Infections; Rabbits | 1995 |
[Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation].
Topics: Animals; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation; Endocarditis, Bacterial; Infusions, Intravenous; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens | 1995 |
Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Lung; Male; Microbial Sensitivity Tests; Pefloxacin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Serum Bactericidal Test | 1995 |
[Effectiveness of new quinolones in experimental aerogenic plague infection of albino mice].
Topics: 4-Quinolones; Administration, Inhalation; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Lethal Dose 50; Mice; Nalidixic Acid; Pefloxacin; Plague; Quinolones | 1994 |
[Comparative evaluation of the effectiveness of fluoroquinolones in experimental anthrax infection].
Topics: Animals; Anthrax; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fluoroquinolones; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Pefloxacin; Quinolones | 1994 |
[Combined use of quinolones with other antibiotics in treatment of experimental plague infection].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Lactams; Mice; Pefloxacin; Plague; Rifampin | 1994 |
In vitro activity of eight antibiotics against Salmonella and Shigella species.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
[Epicondylitis induced by fluoroquinolones in athletes. Apropos of 2 cases].
Topics: Ciprofloxacin; Humans; Lung Diseases; Magnetic Resonance Spectroscopy; Male; Middle Aged; Orchitis; Pefloxacin; Sports; Tennis Elbow; Ultrasonography | 1994 |
The inhibitory effect of fluoroquinolones on Coxiella burnetii growth in in-vitro systems.
Topics: Animals; Anti-Infective Agents; Chick Embryo; Chlorocebus aethiops; Ciprofloxacin; Coxiella burnetii; Fleroxacin; Microbial Sensitivity Tests; Minocycline; Pefloxacin; Vero Cells | 1994 |
Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production.
Topics: Animals; Anti-Infective Agents; Cartilage; Cell Survival; Cells, Cultured; Ciprofloxacin; Flow Cytometry; Free Radicals; Macrophages, Alveolar; Nalidixic Acid; Ofloxacin; Pefloxacin; Rabbits | 1994 |
In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Endocarditis, Bacterial; Female; Humans; Infusions, Intravenous; Pefloxacin; Rabbits; Serratia Infections; Serratia marcescens; Serum Bactericidal Test | 1994 |
[Effectiveness of the new quinolones, ciprofloxacin and pefloxacin in experimental plague].
Topics: Animals; Ciprofloxacin; Evaluation Studies as Topic; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Pefloxacin; Plague | 1993 |
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
Topics: Biological Transport; Carbon Radioisotopes; Cells, Cultured; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Humans; Intestinal Mucosa; Norfloxacin; Ofloxacin; Pefloxacin; Quinolizines | 1994 |
[Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Fluoroquinolones; Helicobacter pylori; Humans; In Vitro Techniques; Ofloxacin; Pefloxacin; Quinolones; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1993 |
Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Topics: Ciprofloxacin; Clindamycin; Dose-Response Relationship, Drug; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbiological Techniques; Nalidixic Acid; Ofloxacin; Pefloxacin; Staphylococcus; Virginiamycin | 1993 |
Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Pefloxacin; Premedication | 1993 |
[Excretion of fluoroquinolones into saliva].
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Mice; Ofloxacin; Pefloxacin; Rabbits; Saliva | 1995 |
In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Fluoroquinolones; Gonorrhea; Humans; Microbial Sensitivity Tests; Naphthyridines; Neisseria gonorrhoeae; Pefloxacin; Penicillins | 1995 |
Modulation of biofilms of Pseudomonas aeruginosa by quinolones.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Catheterization; Ciprofloxacin; Glycoproteins; Norfloxacin; Ofloxacin; Pefloxacin; Polysaccharides; Pseudomonas aeruginosa | 1995 |
[Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Yersinia pseudotuberculosis | 1996 |
Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.
Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Pefloxacin; Quinolones | 1996 |
[Elimination of virulence plasmids of Yersinia pseudotuberculosis as affected by fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Weight; Norfloxacin; Pefloxacin; Plasmids; Virulence; Yersinia pseudotuberculosis | 1996 |
[Use of fluoroquinolones in rheumatology].
Topics: Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Tolerance; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Pefloxacin; Quinolones; Rheumatic Diseases; Time Factors | 1996 |
The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Tobramycin; Type C Phospholipases | 1997 |
Application of terbium sensitized fluorescence for the determination of fluoroquinolone antibiotics pefloxacin, ciprofloxacin and norfloxacin in serum.
Topics: Anti-Infective Agents; Cetylpyridinium; Ciprofloxacin; Fluorescence; Humans; Hydrogen-Ion Concentration; Norfloxacin; Organophosphorus Compounds; Pefloxacin; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Terbium; Time Factors | 1997 |
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Respiratory Tract Infections | 1997 |
Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Depression, Chemical; Dose-Response Relationship, Drug; Gentamicins; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence | 1996 |
Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Cell Wall; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Coloring Agents; Congo Red; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Pefloxacin; Salmonella enteritidis; Salmonella Phages; Salmonella typhimurium; Virus Activation | 1997 |
Periapical abscesses: causal bacteria and antibiotic sensitivity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxalactam; Pefloxacin; Periapical Abscess | 1997 |
A comparative study of anxiogenic effects of fluoroquinolones in rats.
Topics: Animals; Anti-Infective Agents; Anxiety; Ciprofloxacin; Female; Injections, Intraperitoneal; Male; Ofloxacin; Pefloxacin; Rats | 1998 |
Perioperative antibiotic prophylaxis in abdominal surgery for hernia repair: retrospective study of 1,524 consecutive patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Herniorrhaphy; Humans; Male; Middle Aged; Pefloxacin; Retrospective Studies; Surgical Wound Infection; Treatment Outcome | 1998 |
Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; Extremities; Fleroxacin; Fluoroquinolones; Magnesium Deficiency; Mice; Microscopy, Electron; Ofloxacin; Pefloxacin; Quinolones | 1998 |
Postantibiotic effect of some antibiotics on the metabolism of Pseudomonas aeruginosa.
Topics: Adenine; Amikacin; Anti-Bacterial Agents; Carbon Radioisotopes; Cell Division; Ciprofloxacin; Imipenem; Leucine; Meropenem; Nucleic Acid Synthesis Inhibitors; Oxygen Consumption; Pefloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Thienamycins | 1998 |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
Topics: Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Coxiella burnetii; Doxycycline; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin | 1998 |
Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study.
Topics: Anti-Infective Agents; Ciprofloxacin; Dioxanes; Drug Carriers; Lactic Acid; Molecular Weight; Pefloxacin; Polyesters; Polymers; Solubility | 1999 |
The system of objective judgement analysis method: less objectivity than pretended?
Topics: Ciprofloxacin; Dosage Forms; Drug Administration Routes; Drug Utilization; Ofloxacin; Pefloxacin; Statistics as Topic | 1995 |
Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas | 1999 |
In-vitro activity of levofloxacin, a new fluoroquinolone: evaluation against Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Pefloxacin | 1999 |
Adverse testicular effects of some quinolone members in rats.
Topics: Acid Phosphatase; Animals; Anti-Infective Agents; Ciprofloxacin; Fertility; L-Lactate Dehydrogenase; Male; Ofloxacin; Organ Size; Pefloxacin; Prostate; Rats; Sperm Count; Sperm Motility; Testicular Diseases; Testis | 2000 |
[The effect of fluoroquinolones on the adhesive properties of different plasmidovars of Yersinia pseudotuberculosis].
Topics: Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Erythrocytes; Humans; In Vitro Techniques; Norfloxacin; Pefloxacin; Plasmids; Serotyping; Yersinia pseudotuberculosis | 2000 |
[The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 2000 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline | 1999 |
Pefloxacin and ciprofloxacin increase UVA-induced edema and immune suppression.
Topics: Animals; Anti-Infective Agents; Apoptosis; Ciprofloxacin; Dermatitis, Contact; Edema; Female; Immune System; Langerhans Cells; Mice; Mice, Inbred C3H; Pefloxacin; Sunburn; Ultraviolet Rays | 2001 |
Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Catheterization; Ciprofloxacin; Dose-Response Relationship, Drug; Glycocalyx; Microbial Sensitivity Tests; Models, Biological; Norfloxacin; Pefloxacin; Staphylococcus epidermidis | 2001 |
[Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
Topics: Adolescent; Anti-Infective Agents; Arthritis; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Female; Humans; Infant; Knee Joint; Male; Ofloxacin; Pefloxacin; Respiratory Tract Infections | 2001 |
Spectrophotometric determination of ciprofloxacin, enrofloxacin and pefloxacin through charge transfer complex formation.
Topics: Anti-Infective Agents; Benzoquinones; Capsules; Ciprofloxacin; Electron Transport; Enrofloxacin; Ethylenes; Fluoroquinolones; Nitriles; Pefloxacin; Quality Control; Quinolones; Reproducibility of Results; Spectrophotometry; Spectrophotometry, Ultraviolet; Statistics as Topic; Tablets | 2002 |
Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Ethidium; Fluoroquinolones; Genes, MDR; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma hominis; Pefloxacin; Phenotype; Quinolines; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
[Tenotoxic potential of fluoroquinolones in the choice of surgical antibiotic prophylaxis in ophthalmology].
Topics: Achilles Tendon; Aged; Animals; Antibiotic Prophylaxis; Cells, Cultured; Ciprofloxacin; Data Interpretation, Statistical; Fluoroquinolones; Free Radicals; Humans; Levofloxacin; Middle Aged; Ofloxacin; Ophthalmologic Surgical Procedures; Pefloxacin; Rabbits; Rupture; Tendons; Time Factors | 2002 |
The effect of nitric oxide combined with fluoroquinolones against Salmonella enterica serovar Typhimurium in vitro.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella typhimurium; Transcription Factors; Triazenes | 2003 |
A comparison of effects of fluoroquinolones on fracture healing (an experimental study in rats).
Topics: Animals; Ciprofloxacin; Femoral Fractures; Fluoroquinolones; Fracture Healing; Norfloxacin; Ofloxacin; Pefloxacin; Rats; Rats, Wistar | 2005 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Effects of substituents on the NMR features of basic bicyclic ring systems of fluoroquinolone antibiotics and the relationships between NMR chemical shifts, molecular descriptors and drug-likeness parameters.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Magnetic Resonance Spectroscopy; Naphthyridines; Pefloxacin; Quantitative Structure-Activity Relationship | 2010 |
Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats.
Topics: Achilles Tendon; Administration, Oral; Animals; Anti-Bacterial Agents; Ciprofloxacin; Elastic Modulus; Elasticity; Fluoroquinolones; Male; Norfloxacin; Ofloxacin; Pefloxacin; Rats; Rats, Wistar; Tensile Strength | 2011 |
Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability.
Topics: Biological Availability; Buffers; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Absorption; Gatifloxacin; Hydrogen-Ion Concentration; Models, Molecular; Molecular Conformation; Norfloxacin; Octanols; Pefloxacin; Phosphates; Solvents; Static Electricity; Thermodynamics | 2014 |
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacteremia; Base Sequence; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Nalidixic Acid; Ofloxacin; Pefloxacin; Salmonella enterica; Salmonella Infections; Sequence Analysis, DNA | 2015 |
Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Pefloxacin; Salmonella; Salmonella Infections | 2015 |
Use of pefloxacin as a surrogate marker to detect ciprofloxacin susceptibility in Salmonella enterica serotypes Typhi and Paratyphi A.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Humans; Microbial Sensitivity Tests; Pefloxacin; Prospective Studies; Salmonella Infections; Salmonella paratyphi A; Salmonella typhi | 2020 |
Antibiotics and antimycotics in waste water treatment plants: Concentrations, removal efficiency, spatial and temporal variations, prediction, and ecological risk assessment.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clotrimazole; Environmental Monitoring; Moxifloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Purification | 2022 |
Occurrences, transport drivers, and risk assessments of antibiotics in typical oasis surface and groundwater.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; Ecosystem; Environmental Monitoring; Groundwater; Norfloxacin; Oxygen; Pefloxacin; Risk Assessment; Water; Water Pollutants, Chemical | 2022 |
Fluorescent strip sensor for rapid and ultrasensitive determination of fluoroquinolones in fish and milk.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Milk; Norfloxacin; Ofloxacin; Pefloxacin | 2023 |
Pefloxacin and ciprofloxacin in the treatment of uncomplicated gonococcal urethritis in males [corrected].
Topics: 4-Quinolones; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Administration Schedule; Drug Resistance, Microbial; Fluoroquinolones; Gonorrhea; Humans; Male; Middle Aged; Neisseria gonorrhoeae; Pefloxacin; Quinolones; Tetracycline Resistance; Urethritis | 1992 |
Epicondylitis after treatment with fluoroquinolone antibiotics.
Topics: 4-Quinolones; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Male; Middle Aged; Orchitis; Pefloxacin; Quinolones; Respiratory Tract Infections; Tennis Elbow | 1995 |
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.
Topics: 4-Quinolones; Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Mutation; Pefloxacin; Quinolones; Sequence Analysis, DNA; Streptococcus pneumoniae; Transformation, Genetic | 1996 |
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.
Topics: 4-Quinolones; Acriflavine; Adenosine Triphosphate; Anti-Infective Agents; Anti-Infective Agents, Local; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cetrimonium; Cetrimonium Compounds; Ciprofloxacin; Drug Resistance, Microbial; Ethidium; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pefloxacin; Phenotype; Quinolones; Streptococcus pneumoniae; Transformation, Bacterial | 1997 |
Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
Topics: 4-Quinolones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Automation; Ceftazidime; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Netilmicin; Ofloxacin; Pefloxacin; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections | 2000 |
In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Cell Line; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Infusions, Intra-Arterial; Kidney; Mice; Mice, Inbred Strains; Mice, Knockout; Microdialysis; Norfloxacin; Pefloxacin; Recombinant Proteins; Rhodamine 123; Swine; Tissue Distribution; Transfection | 2000 |
[The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
Topics: 4-Quinolones; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Spain | 2001 |
Effect of fluorinated quinolones on heat-labile toxin production by Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Ciprofloxacin; Enterotoxins; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin | 1989 |